Cite
A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells.
MLA
Eller, Michael A., et al. “A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells.” PLoS ONE, vol. 6, no. 9, Sept. 2011, pp. 1–11. EBSCOhost, https://doi.org/10.1371/journal.pone.0024254.
APA
Eller, M. A., Slike, B. M., Cox, J. H., Lesho, E., Zhining Wang, Currier, J. R., Darden, J. M., Polonis, V. R., Vahey, M. T., Peel, S., Robb, M. L., Michael, N. L., & Marovich, M. A. (2011). A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells. PLoS ONE, 6(9), 1–11. https://doi.org/10.1371/journal.pone.0024254
Chicago
Eller, Michael A., Bonnie M. Slike, Josephine H. Cox, Emil Lesho, Zhining Wang, Jeffrey R. Currier, Janice M. Darden, et al. 2011. “A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells.” PLoS ONE 6 (9): 1–11. doi:10.1371/journal.pone.0024254.